Polesel, Marcello http://orcid.org/0000-0003-0668-8099
Ingles-Prieto, Alvaro http://orcid.org/0000-0002-5409-8571
Christodoulaki, Eirini http://orcid.org/0000-0001-9834-1257
Ferrada, Evandro http://orcid.org/0000-0003-3242-1726
Doucerain, Cédric
Altermatt, Patrick
Knecht, Michelle
Kuhn, Michael
Steck, Anna-Lena
Wilhelm, Maria
Manolova, Vania
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (777372)
Article History
Received: 12 October 2022
Accepted: 20 November 2022
First Online: 1 December 2022
Change Date: 24 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10534-024-00615-z
Declarations
:
: M.P., C.D., P.A., M.KN., M.K., A-L.S., M.W., and V.M. are current or past employees of Vifor (International) AG and may own equities. Vifor (International) AG is an in-kind contributor of the RESOLUTE consortium.
: Not applicable.